However, most studies investigating survivin have been conducted in smaller cohorts of predominantly White women or that did not report on race [10, 11, 20–24], and little is known about survivin in tumors from young and Black breast cancer patients, who are more frequently diagnosed with advanced disease, higher grade, and aggressive molecular subtypes [25, 26]. This evidence concerns the gene BIRC5 and breast carcinoma.